Literature DB >> 11596845

Mesoprefrontal dopamine neurons and schizophrenia: role of developmental abnormalities.

J M Finlay1.   

Abstract

Schizophrenia is characterized by a complex array of symptoms that include hallucinations, delusions, abnormal affect, and cognitive deficits. It is becoming increasingly apparent that the symptoms of the disorder are paralleled by equally complex functional and structural abnormalities in brain regions such as the temporal lobe, prefrontal cortex, and thalamus. In addition, the delayed onset of symptoms in late adolescence/early adulthood suggests that abnormal development of the nervous system may ultimately contribute to the neurobiology of the disorder. The present review focuses on clinical and basic research that, together, suggests abnormal development of the dopamine (DA) innervation of prefrontal cortex plays a role in the cognitive deficits of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11596845     DOI: 10.1093/oxfordjournals.schbul.a006885

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  14 in total

1.  Mapping dopaminergic deficiencies in the substantia nigra/ventral tegmental area in schizophrenia.

Authors:  Matthew W Rice; Rosalinda C Roberts; Miguel Melendez-Ferro; Emma Perez-Costas
Journal:  Brain Struct Funct       Date:  2014-10-01       Impact factor: 3.270

Review 2.  Prefrontal dysfunction and a monkey model of schizophrenia.

Authors:  Ping Mao; Ding Cui; Xu-Dong Zhao; Yuan-Ye Ma
Journal:  Neurosci Bull       Date:  2015-03-31       Impact factor: 5.203

3.  Adolescent social defeat alters markers of adult dopaminergic function.

Authors:  Andrew M Novick; Gina L Forster; Shanaz M Tejani-Butt; Michael J Watt
Journal:  Brain Res Bull       Date:  2011-06-30       Impact factor: 4.077

4.  Midbrain dopamine D2/3 receptor binding in schizophrenia.

Authors:  Heli Tuppurainen; Jyrki T Kuikka; Mikko P Laakso; Heimo Viinamäki; Minna Husso; Jari Tiihonen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-16       Impact factor: 5.270

5.  Sex and laterality differences in parkinsonian impairment and transcranial ultrasound in never-treated schizophrenics and their first degree relatives in an Andean population.

Authors:  Danielle Kamis; Lee Stratton; María Calvó; Eduardo Padilla; Néstor Florenzano; Gonzalo Guerrero; Beatriz Molina Rangeon; Juan Molina; Gabriel A de Erausquin
Journal:  Schizophr Res       Date:  2015-02-27       Impact factor: 4.939

6.  How have developments in molecular imaging techniques furthered schizophrenia research?

Authors:  Judy L Thompson; Nina Urban; Anissa Abi-Dargham
Journal:  Imaging Med       Date:  2009-12-01

Review 7.  Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia.

Authors:  Urs Meyer; Joram Feldon
Journal:  Psychopharmacology (Berl)       Date:  2009-03-11       Impact factor: 4.530

8.  Tumor interactions with soluble factors and the nervous system.

Authors:  Melanie J Voss; Frank Entschladen
Journal:  Cell Commun Signal       Date:  2010-09-07       Impact factor: 5.712

Review 9.  Developmental origins of brain disorders: roles for dopamine.

Authors:  Kelli M Money; Gregg D Stanwood
Journal:  Front Cell Neurosci       Date:  2013-12-19       Impact factor: 5.505

10.  Stochastic Mesocortical Dynamics and Robustness of Working Memory during Delay-Period.

Authors:  Melissa Reneaux; Rahul Gupta
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.